MACAN WILLIAM ANDREW 4
4 · Neuronetics, Inc. · Filed Mar 24, 2026
Research Summary
AI-generated summary of this filing
Neuronetics (STIM) EVP/CLO William Macan Sells 16,005 Shares
What Happened
- William Macan, EVP, Chief Legal Officer and Corporate Secretary of Neuronetics, sold 16,005 shares on March 19, 2026. The weighted-average sale price reported was $1.34 per share for total proceeds of approximately $21,447. The filing identifies the sales as non‑discretionary transactions to satisfy tax withholding upon vesting of a portion of a performance restricted stock unit award.
Key Details
- Transaction date: 2026-03-19; filing date (Form 4): 2026-03-24 (appears to be filed one business day late).
- Reported price: weighted average $1.34; per-share prices in the sales ranged from $1.48 to $1.20 (multiple transactions).
- Shares sold: 16,005; total proceeds ≈ $21,447.
- Footnote: F1 states sales were to satisfy tax withholding on PRSU vesting; F2 notes the weighted-average price and offers to provide a breakdown of shares sold at each price on request.
- Shares owned after the transaction were not included in the provided excerpt.
Context
- This sale appears to be a routine, non‑discretionary tax‑withholding disposition tied to equity vesting rather than an outright investment decision. Such withholding sales are common and do not necessarily signal insider sentiment about the company's prospects.
Insider Transaction Report
Form 4
MACAN WILLIAM ANDREW
EVP, CLO and CS
Transactions
- Sale
Common Stock
[F1][F2]2026-03-19$1.34/sh−16,005$21,447→ 897,270 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Patrick Devine, as Attorney-in-Fact|2026-03-24